[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356743-105":59,"doc-detail-356743-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-m6a-circrna-axis-a-therapeutic-prospect-for-gastric-cancer","The m6A-circRNA axis - a therapeutic prospect for gastric cancer","","Gastric cancer remains a major global health burden, while resistance to conventional therapy restricts durable clinical benefit. Mechanistic and translational evidence highlights the N6-methyladenosine (m6A)–circular RNAs (circRNAs) axis as a regulatory network driving gastric cancer progression and therapeutic resistance. The review describes how m6A RNA modification and circRNAs jointly regulate chemoresistance, immune evasion, metabolic reprogramming, and resistance to cell death. Emerging therapeutic strategies targeting this axis are evaluated, including standalone modulation or combination approaches to address multidrug resistance and improve clinical outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-m6a-circrna-axis-a-therapeutic-prospect-for-gastric-cancer/356743/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-m6a-circrna-axis-a-therapeutic-prospect-for-gastric-cancer/356743.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does the m6A–circRNA axis play in gastric cancer?","Question",{"text":113,"@type":114},"It acts as a critical regulatory network influencing gastric cancer progression and therapeutic resistance through coordinated m6A RNA modification and circRNA functions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which biological processes are linked to m6A-modified circRNAs in gastric cancer?",{"text":118,"@type":114},"They are associated with chemoresistance, immune evasion, metabolic reprogramming, transcript stability changes, and resistance to cell death.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the review propose targeting the m6A–circRNA axis for therapy?",{"text":122,"@type":114},"By modulating the axis either as a standalone approach or in combination with existing treatments to overcome multidrug resistance and improve clinical outcomes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356743,1790193830,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Cell Biol Toxicol (2026) 42:59  \n[https://doi.org/10.1007/s10565-026-10184-1](https://doi.org/10.1007/s10565-026-10184-1)  \nThe m6A‑circRNA axis: a therapeutic prospect for gastric cancer  \nZijia Li · Yiwei Gu · Hui Gu · Qing‑Bai She · Yuxin Tong  \nReceived: 15 December 2025 / Accepted: 23 March 2026 © The Author(s) 2026  \nAbstract Gastric cancer (GC) remains a major global health burden, and resistance to conventional therapies continues to limit durable clinical benefit. Increasing evidence identifies the N6-methyladenosine (m6A)–circular RNAs (circRNAs) axis as a critical regulatory network driving GC progression and therapeutic resistance. The functional interplay between m6A RNA modification and circRNAs contributes to key oncogenic processes, including chemoresistance, immune evasion, metabolic reprogramming, and resistance to cell death. In particular, m6A-modified circRNAs promote tumor progression by enhancing transcript stability, facilitating oncogenic signaling, modulating immune checkpoint pathways, and supporting metabolic adaptation under therapeutic stress. In this review, we synthesize current advances in understanding the mechanistic and translational significance of the m6A–circRNA axis  \nin GC. We examine how this regulatory interface orchestrates adaptive resistance and evaluate emerging therapeutic strategies aimed at targeting its components. Modulating the m6A–circRNA axis—either as a standalone approach or in combination with existing treatments—represents a promising strategy to overcome multidrug resistance and improve clinical outcomes in GC.  \nKeywords M6A-circRNAs axis · Drug resistance · Metabolic reprogramming · Immune evasion · Gastric cancer  \nIntroduction  \nGastric cancer (GC) remains a major global health burden, with over 968,000 new cases and nearly  \nZijia Li and Yiwei Gu contributed equally to this work.  \nZ. Li · Y. Tong (*)  \nMedical Research Center, Liaoning Key Laboratory of Research and Application of Animal Models for Environmental and Metabolic Diseases, Shengjing Hospital of China Medical University, \\#36 Sanhao Street, Heping District, Shenyang 110004, China  \ne-mail: [yxtong@cmu.edu.cn](yxtong@cmu.edu.cn)  \n[Y](Y). Gu · Q.-B. She (*)  \nMarkey Cancer Center, University of Kentucky College of Medicine, Lexington, KY 40506, USA  \ne-mail: [qing-bai.she@uky.edu](qing-bai.she@uky.edu)  \nY. Gu · Q.-B. She  \nDepartment of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40506, USA  \nH. Gu (*)  \nKey Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang, China [e-mail: huier.99@hotmail.com](e-mail: huier.99@hotmail.com)  \nY. Tong  \nDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China  \n660,000 deaths reported in 2022 (Bray et al. 2024) . Although clinical management has advanced substantially—ranging from endoscopic resection for earlystage disease to perioperative chemotherapy, targeted therapy, and chemo-immunotherapy for advanced stages (Shitara et al. 2024 ; Yoo et al. 2024)—longterm survival remains unsatisfactory. Multidrug resistance, compounded by treatment-related toxicity and comorbidities, continues to limit durable therapeutic responses (Alsina et al. 2023) . These challenges highlight the urgent need to identify regulatory mechanisms that drive adaptive tumor plasticity and therapeutic failure.  \nGC is increasingly recognized as a biologically heterogeneous disease shaped by both tumor-intrinsic alterations and microenvironmental interactions.  \nStromal and immune components, including cancerassociated fibroblasts and myeloid cells, actively remodel the tumor microenvironment to promote immune suppression and resistance (Peng et al. 2024) . Genomic alterations further contribute to this diversity; for example, FAT4 mutations correlate with distinct immune landscapes and tumor mutation burden (Li et al. 202","cbCaikFNEe8dV2BQ","https://ap.wps.com/l/cbCaikFNEe8dV2BQ","pdf",4215849,24,"English","# Abstract\n# Introduction\n## Gastric cancer burden and treatment limitations\n## Tumor heterogeneity and microenvironment interactions\n## m6A RNA modification as a post-transcriptional regulator\n## circRNAs as stable regulatory RNAs","[{\"question\":\"What role does the m6A–circRNA axis play in gastric cancer?\",\"answer\":\"It acts as a critical regulatory network influencing gastric cancer progression and therapeutic resistance through coordinated m6A RNA modification and circRNA functions.\"},{\"question\":\"Which biological processes are linked to m6A-modified circRNAs in gastric cancer?\",\"answer\":\"They are associated with chemoresistance, immune evasion, metabolic reprogramming, transcript stability changes, and resistance to cell death.\"},{\"question\":\"How does the review propose targeting the m6A–circRNA axis for therapy?\",\"answer\":\"By modulating the axis either as a standalone approach or in combination with existing treatments to overcome multidrug resistance and improve clinical outcomes.\"}]","The m6A-circRNA axis - a therapeutic prospect for gastric cancer | PDF",1790127076,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71f08c194adc96bbc661ac93104cd3d9.webp",983,1324,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d4d1bdf0c575799d9f656b08bde7361.webp",982,1322,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/306c4d6c960af3f0186e397d2df17600.webp",981,1321,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d41fc4b6b24bd33626f5e58ffda7bad3.webp",980,1319]